/

Other

/

Hikma Pharmaceuticals

Hikma Pharmaceuticals

Hikma Pharmaceuticals

Verified Nov 2026

Other

·

United Kingdom flag

·

Since 1978

Hikma Pharmaceuticals is a British multinational pharmaceutical manufacturer founded in 1978, headquartered in London and employing 5,000–10,000 people. The company produces sterile injectable medicines, generic pharmaceuticals, and branded products across respiratory, oncology, pain management, and cardiovascular areas, serving hospitals and healthcare providers globally. In 2026, Hikma announced a $267 million investment in Ohio manufacturing facilities to expand capacity and create 350 jobs.

Hikma Pharmaceuticals

Verified Nov 2026

AT A GLANCE

Founded

1978

Headquarters

United Kingdom flag

Employees

5,000-10,000

Ownership

Hikma Pharmaceuticals at a glance

Revenue

$1-5B

Est. band

Employees

5,000-10,000

Founded

1978

Import activity

5478

Industries

Automotive

Electric Vehicles

Medical

Renewable Energy

Industrial Equipment

Sourcing and import activity

From US customs bill-of-lading records

US sea imports

5478

Named foreign suppliers

50

Top origins

Portugal · Germany · Morocco · Spain

Chart of the supplier's US import shipment volume trend over time

Shared foreign counterparties do not establish that these companies buy from Hikma Pharmaceuticals.

What this tells a buyer

Hikma recorded 5,478 total shipments across customs records, with supply origins in Portugal (3,837 shipments), Switzerland (1,223 shipments), and Germany (515 shipments combined), alongside sourcing from India, China, and other regions.

The company operates 29 manufacturing plants and 9 R&D centers, producing sterile injectable generics, oral generics, and biosimilar biologics with focus on regulatory compliance and quality assurance across multiple therapeutic areas.

Hikma operates in three main business segments—Injectables, Generics, and Branded products—and ranks among sterile injectable manufacturers in the United States, serving thousands of hospitals and millions of patients worldwide.

Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026

STABILITY SIGNALS

Established & active

48 years in operation (founded 1978).

5,478 US import shipments on record.

Overview

Hikma Pharmaceuticals is a British multinational pharmaceutical manufacturer founded in 1978, headquartered in London and employing 5,000–10,000 people. The company produces sterile injectable medicines, generic pharmaceuticals, and branded products across respiratory, oncology, pain management, and cardiovascular areas, serving hospitals and healthcare providers globally. In 2026, Hikma announced a $267 million investment in Ohio manufacturing facilities to expand capacity and create 350 jobs.

At a glance

Attribute

Detail

Founded

1978

Employees

5,000-10,000

Revenue

$1-5B (estimated)

What Hikma Pharmaceuticals makes

The company operates 29 manufacturing plants and 9 R&D centers, producing sterile injectable generics, oral generics, and biosimilar biologics with focus on regulatory compliance and quality assurance across multiple therapeutic areas.

Products and capabilities described on the company's own site include Assembly (source: hikma.com).

Trade and customs footprint

Hikma recorded 5,478 total shipments across customs records, with supply origins in Portugal (3,837 shipments), Switzerland (1,223 shipments), and Germany (515 shipments combined), alongside sourcing from India, China, and other regions. US customs bill-of-lading records list 5478 inbound shipments across 50 foreign suppliers, with top origins including Portugal · Germany · Morocco · Spain.

Latest developments

Facilities

Public sources reference the following locations:

Company details

Hikma operates in three main business segments—Injectables, Generics, and Branded products—and ranks among sterile injectable manufacturers in the United States, serving thousands of hospitals and millions of patients worldwide. Hikma Pharmaceuticals was founded in 1978, and has an estimated 5,000-10,000 employees. On the LightSource stability read it is rated "Established & active": 48 years in operation (founded 1978). 5,478 US import shipments on record.

Frequently asked questions

What does Hikma Pharmaceuticals do?

Hikma Pharmaceuticals is a British multinational pharmaceutical manufacturer founded in 1978, headquartered in London and employing 5,000–10,000 people. The company produces sterile injectable medicines, generic pharmaceuticals, and branded products across respiratory, oncology, pain management, and cardiovascular areas, serving hospitals and healthcare providers globally. In 2026, Hikma announced a $267 million investment in Ohio manufacturing facilities to expand capacity and create 350 jobs.

When was Hikma Pharmaceuticals founded?

Hikma Pharmaceuticals was founded in 1978.

How big is Hikma Pharmaceuticals?

Hikma Pharmaceuticals has an estimated 5,000-10,000 employees, with revenue in the $1-5B range (estimated).

Does Hikma Pharmaceuticals import from overseas suppliers?

US customs bill-of-lading records show 5478 inbound shipments for Hikma Pharmaceuticals, with top origins including Portugal · Germany · Morocco · Spain.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

EnglandHeadquarters · S 2HR, United Kingdom
England1 New Burlington Place, England, W1S 2HR, United KingdomHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.